BioLife Solutions Announces CFO Retirement
09/15/2021 - 08:00 AM
BOTHELL, Wash. , Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that Roderick de Greef , Chief Financial Officer, plans to retire on December 31, 2021 after a distinguished career with the Company. The Company has retained executive search firm Strawn Arnold to identify candidates to succeed Mr. de Greef. Mr. de Greef will consult with the Company through March 31, 2022 , to ensure an orderly transition of his duties.
Mike Rice , BioLife CEO, commented, "The entire team, our board and shareholders are extremely grateful to Rod for his 20+ years of contributing to the success of BioLife. He was instrumental in securing funding in the early years and during his long tenure first as a board member and later as CFO, Rod has had an immeasurable positive impact as we scaled the business organically and though our acquisitions over the past two years. We will miss him but wish him the best in a well-deserved retirement."
De Greef added, "It has been a real honor to be a part of the team that has built BioLife to what it is today. The last five years as CFO have been particularly rewarding and a great capstone to a career spanning forty years. In the future, I look forward to watching the company continue to grow and thrive."
About BioLife Solutions
BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems® high-capacity cryogenic freezers, Stirling Ultracold ULT freezers, and SciSafe biologic materials storage. For more information, please visit www.biolifesolutions.com , www.scisafe.com , www.stirlingultracold.com , www.sextonbio.com and follow BioLife on Twitter .
Contacts:
At the Company Roderick de Greef Chief Financial Officer (425) 686-6002 rdegreef@biolifesolutions.com
Investors LHA Investor Relations Jody Cain (310) 691-7100 jcain@lhai.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-announces-cfo-retirement-301377282.html
SOURCE BioLife Solutions, Inc.
BLFS Rankings
#4918 Ranked by Stock Gains
BLFS Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
Country
US
City
Bothell
About BLFS
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.